SUBSCRIBE Blog with us: BLOGbiotech

GEN News Highlights

• Email
• Print
• Share
• More GEN News Highlights

Oct 27 2009, 10:33 AM EST

FDA Approves AdvanDx’ Faster PNA FISH Protocol for Identifying Enterococcal Bloodstream Pathogens

GEN News Highlights

AdvanDx received FDA 510(k) clearance for a 90-minute protocol for its Enterococcus faecalis/OE PNA FISH® test. Enterococcus species cause bloodstream infections (BSI). While infections with E. faecalis are generally susceptible to ampicillin and rarely resistant to vancomycin, infections with E. faecium and other enterococci (OE) are frequently resistant to both drugs. Since conventional identification methods can take three days or longer, the company points out, up to 80% of vancomycin-resistant enterococci receive inappropriate antibiotic therapy.

AdvanDx reports that its new protocol reduces the PNA FISH turnaround time from two and half hours to 90 minutes by decreasing PNA probe hybridization from 90 minutes to 30 minutes. Clinical validation studies performed at hospitals in the U.S. and Europe demonstrated 100% equivalence between the 90-minute protocol and the original PNA FISH protocol, the company adds. E. faecalis/OE PNA FISH® is distributed by bioMerieux in the U.S.

“The faster protocol marks another milestone toward AdvanDx’ goal of providing a fast, easy-to-use, and broad molecular diagnostic platform for early identification of bloodstream pathogens,” remarks Thais T. Johansen, president and CEO. “With results in 90 minutes, hospitals will be able to provide critical results as early as possible, enabling clinicians to improve care and outcomes for patients with life-threatening infections.”

 

♦♦♦
Related News
Abbott and BioGenex Continue Partnership to Automate FISH Assay Workflow (June 2, 2009)
PolyOrg to Manufacture and Distribute PNA Monomers Worldwide (Jan. 14, 2009)
Researchers Refine FISH to See DNA Made into RNA at the Cellular Level (Dec. 3, 2008)
AdvanDx Inks Panagene as Supplier of PNA Probes (June 11, 2007)

• Email
• Print
• Share
• More GEN News Highlights

Comment on this News:

Name:
Title:
Comment:
	HELP US FIGHT SPAMMING ROBOTS by answering the following simple question. It will verify you as a legitimate user wishing to post a comment. Thank you for your cooperation.

CAREER CENTER

WEBINARS

PODCASTS

MOST POPULAR